mynth
06/2013

ANTELLIQ acquired by BC PARTNERS

FRANCE Life Sciences / Animal Health EV €1–10bn

Context

BC Partners has successfully finalized the acquisition of a majority stake in the share capital of the target from a UK-based investment trust. This strategic transaction represents a secondary leveraged buyout designed to accelerate the organization’s shift toward electronic identification and digital monitoring technologies. The strategic rationale for the move centers on the acquirer's objective to capitalize on the increasing global adoption of mandatory livestock traceability and the rising demand for sophisticated animal intelligence solutions.

ANTELLIQ, which reported an EBITDA margin of [members only] in 2012, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Antelliq is a specialized technology organization dedicated to the development and deployment of digital identification, traceability, and monitoring solutions for animals. The entity’s business model focuses on providing high-precision hardware and data analytics to facilitate the management of livestock and companion animals. Its value proposition is anchored in enhancing animal welfare and productivity through real-time health and behavioral insights. Strategically, the firm operates at the intersection of veterinary science and digital reality, utilizing proprietary sensors and tracking software to provide actionable data for farmers and veterinarians. By maintaining a leadership position in the global animal intelligence market, the organization ensures a mission-critical role in the agricultural supply chain and pet care ecosystems. The entity emphasizes industrialized reliability to address the increasing demand for food safety and personalized animal care.

Ent. Value

€1–10bn

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2012
€150–250M
[members only]
[members only]
2011
€150–250M
[members only]
[members only]

Other operations with ANTELLIQ

Other operations with ANTELLIQ

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
12/2018MERCK & CO.ANTELLIQFRANCEAnimal Health
03/2016PSP INVESTMENTSANTELLIQFRANCEAnimal Health

REFERENCES

Valuation range: EV €1–10bn

Revenue range: €150–250M

EV/Revenue range: 2x - 6x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ANTELLIQ by BC PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: bc partners